Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard ...
Europe’s still asking questions about novel food submission
A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA)
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
